CCL5 and atherosclerosis: Combination of CXCL4 and CCL5 was shown to exacerbate disease in a mouse model of atherosclerosis (59), and CXCL12 in combination with HMGB1 enhanced monocyte recruitment in a mouse model of tissue damage (49).